TY  - BOOK
T1  - Developments in the prescription drug market :oversight : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016.
CN  - Y 4.G 74/7:114-132
N1  - "Serial no. 114-132."
N1  - Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.
N1  - Shipping list no.: 2017-0164-M.
ID  - 1387189
KW  - Prescription pricing
KW  - Pharmaceutical industry
KW  - Generic drugs
KW  - Drug approval
KW  - Drug approval.
KW  - Generic drugs
KW  - Pharmaceutical industry
KW  - Prescription pricing.
TI  - Developments in the prescription drug market :oversight : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016.
LK  - http://purl.fdlp.gov/GPO/gpo82526
UR  - http://purl.fdlp.gov/GPO/gpo82526
ER  -